Glutamic acid as anticancer agent: An overview

Saudi Pharmaceutical Journal

Volumn 21, Issue 4, 2013, Pages 337-343

  Dutta, Satyajit ^a   Ray, Supratim ^b   Nagarajan, K ^c  

^a School of Engineering and Technology   (India)

^b Dr B C Roy College of Pharmacy and Allied Health Sciences   (India)

^c KRISHNA INSTITUTE OF ENGINEERING AND TECHNOLOGY   (India)

Author keywords

Anticancer agent; Glutamate; Glutamic acid; Glutamine

Indexed keywords

20(S) CAMPTOTHECIN; AMINOPTERIN; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; BUFFER; CHELATING AGENT; CISPLATIN; FENRETINIDE; FLAVORING AGENT; FOLIC ACID; GLUTAMATE AMMONIA LIGASE; GLUTAMATE DECARBOXYLASE; GLUTAMATE DEHYDROGENASE; GLUTAMIC ACID; GLUTAMINASE; GLUTAMINE; METHOTREXATE; NEUROTRANSMITTER; PACLITAXEL; POLYGLUTAMIC ACID; RETINOIC ACID; SURFACTANT; THALIDOMIDE; THEANINE; UNCLASSIFIED DRUG;

AGRICULTURE; AMINO ACID METABOLISM; AMINO ACID TRANSPORT; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER RISK; CELL COMPONENT; CHEMICAL STRUCTURE; CULTURE MEDIUM; CUTANEOUS T CELL LYMPHOMA; DNA SYNTHESIS; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG SOLUBILITY; ENZYME METABOLISM; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; IMMUNE RESPONSE; LARGE CELL LYMPHOMA; MUSCLE; MYCOSIS FUNGOIDES; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PROMYELOCYTIC LEUKEMIA; REVIEW; TABLET;

EID: 84884532850     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2012.12.007     Document Type: Review

References (36)

1. Bannai S., Ishii T. A novel function of glutamine in cell culture: utilization of glutamine for the uptake of cystine in human fibroblast. J. Cell. Physiol. 1988, 137(2):360-366. 10.1002/jcp. 1041370221.
2. Boehm K., Borrelli F., Ernst E., Habacher G., Hung S.K., Milazzo S., Horneber M. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst. Rev. 2009, (3). CD005004. doi: 10.1002/14651858.CD005004.pub2.
3. Boksha I.S., Tereshkina E.B., Burbayeva G.S. Isolation and some properties of glutamine synthetase from human brain. Biokhimiia (Mosc) 1995, 60(10):1697-1705. (Rus).
4. Cui C., Zhang Y., Wang L., Liu H., Cui G. Enhanced anticancer activity of glutamate prodrugs of all-trans retinoic acid. J. Pharm. Pharmacol. 2009, 61(10):1353-1358. 10.1211/jpp. 61.10.0012.
5. DeBerardinis R.J., Mancuso A., Daikhin E., Nissim I., Yudkoff M., Wehrli S., Thompson C.B. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. 2007, 104(49):19345-19350. 10.1073/pnas.0709747104.
6. Dewald H.A., Moore A.M. 6-Diazo-5-oxo-l-norleucine, a new tumor-inhibitory substance. Preparation of l-, d- and DL-forms. J. Am. Chem. Soc. 1958, 80(15):3941-3945. 10.1021/ja01548a036.
7. Dubey S.K., Sharma A.K., Narain U., Misra K., Pati U. Design, synthesis and characterization of some bioactive conjugates of curcumin with glycine, glutamic acid, valine and demethylenated piperic acid and study of their antimicrobial and antiproliferative properties. Eur. J. Med. Chem. 2008, 43(9):1837-1846. .
8. Dutta S., Ray S., Nagarajan K. Glutamic acid analogues used as potent anticancer: a review. Der Pharm. Chem. 2011, 3(2):263-272.
9. γ-Aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site. Bioorg. Med. Chem. 2005, 13(4):1111-1118. .
10. Giovannucci E., Stampfer M.J., Colditz G.A., Hunter D.J., Fuchs C., Rosner B.A., Speizer F.E., Willett W.C. Multivitamin use, folate and colon cancer in women in the Nurses' health study. Ann. Intern. Med. 1998, 129(7):517-524.
11. Hatzivassiliou G., Zhao F., Bauer D.E., Andreadis C., Shaw A.N., Dhanak D., Hingorani S.R., Tuveson D.A., Thompson C.B. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 2005, 8(4):311-321. .
12. Kelly A., Stanley C.A. Disorders of glutamate metabolism. Ment. Retard. Dev. Disabil. Res. Rev. 2001, 7(4):287-295. 10.1002/mrdd.1040.
13. Kulkarni C., Kulkarni K.S., Hamsa B.R. l-Glutamic acid and glutamine: exciting molecules of clinical interest. Indian J. Pharmacol. 2005, 37(3):148-154. 10.4103/0253-7613.16210.
14. Luzzio F.A., Mayorov A.V., Figg W.D. Thalidomide metabolites. Part 1: derivatives of (+)-2-(N-phthalimido)-γ-hydroxyglutamic acid. Tetrahedron Lett. 2000, 41(14):2275-2278. .
15. McPhee S.J., Papadakis M.A., Rabow M.W. Current Medical Diagnosis and Treatment 2011 2011, Lange Medical Books/McGraw-Hill, New York. 50 ed.
16. Medina M.A., Sanchez-Jimenez F., Marquez J., Quesada A.R., Castro I.N. Relevance of glutamine metabolism to tumour cell growth. Mol. Cell. Biochem. 1992, 113(1):1-15.
17. Moreadith R.W., Lehninger A.L. The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. Role of mitochondrial NAD(P)+-dependent malic enzyme. J. Biol. Chem. 1984, 259(10):6121-6215.
18. Nicklin P., Bergman P., Zhang B., Triantafellow E., Wang H., Nyfeler B., Yang H., Hild M., Kung C., Wilson C., Myer V.E., MacKeigan J.P., Porter J.A., Wang Y.K., Cantley L.C., Finan P.M., Murphy L.O. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 2009, 136(3):521-534. .
19. Nimmo G.A., Tipton K.F. The distribution of soluble and membrane-bound forms of glutaminase in pig brain. J. Neurochem. 1979, 33(5):1083-1084. 10.1111/j.1471-4159.1979.tb05245.x.
20. Nishiyama N., Kato Y., Sugiyama Y., Kataoka K. Cisplatin-loaded polymer-metal complex micelle with time-modulated decaying property as a novel drug delivery system. Pharm. Res. 2001, 18(7):1035-1041.
21. Oaks B.M., Dodd K.W., Meinhold C.L., Jiao L., Church T.R., Stolzenberg-Solomon R.Z. Folate intake, post-folic acid grain fortification, and pancreatic cancer risk in the prostate, lung, colorectal and ovarian cancer screening trial. Am. J. Clin. Nutr. 2010, 91(2):449-455. 10.3945/ajcn.2009.28433.
22. Oldham E.A., Lic K.S., Wallace S., Huang P. Comparison of action of paclitaxel and poly(l-glutamic acid)-paclitaxel conjugate in human breast cancer cells. Indian J. Oncol. 2000, 16:125-132.
23. Percival S.S., Bukowski J.F., Milner J. Bioactive food components that enhance γδ T cell function may play a role in cancer prevention. J. Nutr. 2008, 138(1):1-4.
24. Plaitakis A., Berl S., Yahr M.D. Neurological disorders associated with deficiency of glutamate dehydrogenase. Ann. Neurol. 1984, 15(2):144-153. 10.1002/ana.410150206.
25. Shih I.L., Van Y.T., Shen M.H. Biomedical applications of chemically and microbiologically synthesized poly(glutamic acid) and poly(lysine). Mini Rev. Med. Chem. 2004, 4(2):179-188.
26. Singer J.W., Bhatt R., Tulinsky J., Buhler K.R., Heasley E., Klein P., de Vries.P. Water-soluble poly-(l-glutamic acid)-gly-camptothecin conjugates enhance camptothecin stability and efficacy in vivo. J. Controlled Release 2001, 74(1-3):243-247. .
27. Skeel R.T. Hand Book of Cancer Chemotherapy 2008, Lippincott, Williams & Wilkins, New York. seventh ed.
28. Srikanth K., Kumar C.A., Ghosh B., Jha T. Synthesis, screening and quantitative structure-activity relationship (QSAR) studies of some glutamine analogues for possible anticancer activity. Bioorg. Med. Chem. 2002, 10(7):2119-2131. .
29. Stamler J., Brown I.J., Daviglus M.L., Chan Q., Kesteloot H., Ueshima H., Zhao L., Elliott P. Glutamic acid-the main dietary amino acid and blood pressure: the INTERMAP study (international collaborative study of macronutrients, micronutrients and blood pressure). Circulation 2009, 120(3):221-228. 10.1161/CIRCULATIONAHA.108.839241.
30. Vila J., Thomasset N., Navarro C., Doré J.F. In vitro and in vivo anti-tumor activity of l-glutamic acid γ-monohydroxamate against L1210 leukemia and B16 melanoma. Int. J. Cancer 1990, 45(4):737-743. 10.1002/ijc.2910450428.
31. Vishwanathan C.L., Deb S., Jain A., Lokhande T., Juvekar A. Synthesis and evaluation of l-glutamic acid analogs as potential anticancer agents. Indian J. Pharm. Sci. 2008, 70(2):245-249. 10.4103/0250-474X.41467.
32. Wise D.R., Thompson C.B. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem. Sci. 2010, 35(8):427-433. .
33. Xu H., Jiang M., Li H., Lu D., Ouyang P. Efficient production of poly(γ-glutamic acid) by newly isolated Bacillus subtilis NX-2. Process Biochem. 2005, 40(2):519-523. .
34. Ye H., Jin L., Hu R., Yi Z., Li J., Wu Y., Xi X., Wu Z. Poly (γ,l-glutamic acid)-cisplatin conjugate effectively inhibits human breast tumor xenografted in nude mice. Biomaterials 2006, 27(35):5958-5965. .
35. Zaganas I., Kanavouras K., Mastorodemos V., Latsoudis H., Spanaki C., Plaitakis A. The human GLUD2 glutamate dehydrogenase: localization and functional aspects. Neurochem. Int. 2009, 55(1-3):52-63. .
36. Zou C., Brewer M., Cao X., Zang R., Lin J., Deng Y., Li C. Antitumor activity of 4-(N-hydroxyphenyl) retinamide conjugated with poly (l-glutamic acid) against ovarian cancer xenografts. Gynecol. Oncol. 2007, 107(3):441-449. .